Jakris Eu-Ahsunthornwattana

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GenomicsEpigenetics (incl. genome methylation and epigenomics)Epidemiological modellingPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2025
EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients.

Saad Ahmed, Jakris Eu-Ahsunthornwattana, Thanaporn Thamrongjirapat

|Oct 25, 2024
Thai pharmacogenomics database -2 (TPGxD-2) sequel to TPGxD-1, analyzing genetic variants in 26 non-VIPGx genes within the Thai population.

Shobana John, Sommon Klumsathian, Paravee Own-Eium

|Jun 10, 2024
A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.

Shobana John, Sommon Klumsathian, Paravee Own-Eium

|Jul 02, 2020
PROC Promoter Single Nucleotide Polymorphisms Associated With Low Protein C Activity But Not Increased Risk of Thromboembolism in Pediatric Population.

Natsumon Udomkittivorakul, Werasak Sasanakul, Jakris Eu-Ahsunthornwattana

|Sep 13, 2019
Contribution of Four Polymorphisms in Renin-Angiotensin-Aldosterone-Related Genes to Hypertension in a Thai Population.

Pimphen Charoen, Jakris Eu-Ahsunthornwattana, Nisakron Thongmung

Pageof 1